Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36.
暂无分享,去创建一个
C. van Broeckhoven | S. Engelborghs | P. D. De Deyn | J. Theuns | K. Peeters | K. Nuytemans | D. Crosiers | E. Elinck | E. Corsmit | M. Mattheijssens | Bram Meeus | P. D. de Deyn | Maria Mattheijssens | Karen Nuytemans
[1] A. Miyashita,et al. A mutant PSEN1 causes dementia with lewy bodies and variant Alzheimer's disease , 2005, Annals of neurology.
[2] Wessel N. van Wieringen,et al. CGHcall: Calling aberrations for array CGH tumor profiles. , 2008 .
[3] C. Lázaro,et al. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations , 2009, Human mutation.
[4] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[5] G. Matthijs,et al. Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia , 2009, Human mutation.
[6] C. van Broeckhoven,et al. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population , 2009, Human mutation.
[7] M. Kokai,et al. Familial dementia with Lewy bodies (DLB). , 1999, Clinical neuropathology.
[8] D. Campion,et al. INTRAFAMILIAL DIVERSITY OF PHENOTYPE ASSOCIATED WITH APP DUPLICATION , 2008, Neurology.
[9] D. Cordato,et al. Dementia with Lewy bodies in an elderly Greek male due to α-synuclein gene mutation , 2006, Journal of Clinical Neuroscience.
[10] K. Sleegers,et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. , 2006, Brain : a journal of neurology.
[11] S. Brennan,et al. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment , 2009, Human mutation.
[12] T. Meitinger,et al. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[13] Irene Litvan,et al. Lrrk2 and Lewy body disease , 2006, Annals of neurology.
[14] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[15] K. Sleegers,et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. , 2006, American journal of human genetics.
[16] C. Brayne,et al. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. , 2005, Age and ageing.
[17] G. Schellenberg,et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. , 2008, Archives of neurology.
[18] C. Waters,et al. Autosomal dominant Lewy body parkinsonism in a four‐generation family , 1994, Annals of neurology.
[19] J. Trojanowski,et al. Beta-synuclein gene alterations in dementia with Lewy bodies. , 2004, Neurology.
[20] Douglas C. Miller,et al. A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.
[21] K. Marder,et al. Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.
[22] C. Duijn,et al. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. , 2000, Human molecular genetics.
[23] D. Dickson,et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. , 2007, Brain : a journal of neurology.
[24] F. Tagliavini,et al. A novel PSEN2 mutation associated with a peculiar phenotype , 2008, Neurology.
[25] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[26] T. Bird,et al. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.
[27] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[28] J. Trojanowski,et al. β-Synuclein gene alterations in dementia with Lewy bodies , 2004, Neurology.
[29] J. Trojanowski,et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders , 2006, Neurology.
[30] M. Farrer,et al. Glucosidase-beta variations and Lewy body disorders. , 2009, Parkinsonism & related disorders.
[31] Z. Wszolek,et al. Familial parkinsonism, dementia, and lewy body disease: Study of family G , 1997, Annals of neurology.
[32] C. van Broeckhoven,et al. novoSNP, a novel computational tool for sequence variation discovery. , 2005, Genome research.
[33] J. Morris,et al. Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. , 2002, Neurology.
[34] K. Sleegers,et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.
[35] 齋藤 和美. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease , 2006 .
[36] D. Cordato,et al. Dementia with Lewy bodies in an elderly Greek male due to alpha-synuclein gene mutation. , 2006, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
[37] J R O'Connell,et al. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.
[38] Bassem A. Hassan,et al. Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.
[39] J. Ott,et al. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.
[40] K. Sakai,et al. A patient with dementia with Lewy bodies and codon 232 mutation of PRNP , 2002, Neurology.
[41] A. Munnich,et al. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence , 2009, Nature Genetics.